gallbladder carcinoma
Showing 1 - 18 of 18
Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)
Recruiting
- Minimal Residual Disease
- +11 more
- ELI-002 2P
-
Duarte, California
- +10 more
Jan 18, 2023
Therapeutic Assistance and Decision-making Algorithms in
Not yet recruiting
- Hepatocellular Carcinoma
- +5 more
- ADBoard
-
Berlin, GermanySurgical Clinic, Campus Virchow-Klinikum / Campus Charité Mitte,
Jan 12, 2023
Gallbladder Carcinoma Trial in Shanghai (gemcitabine and oxaliplatin., Afatinib)
Recruiting
- Gallbladder Carcinoma
- gemcitabine and oxaliplatin.
- Afatinib
-
Shanghai, Shanghai, China
- +1 more
Dec 21, 2022
Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Duarte (Cisplatin, Gemcitabine,
Suspended
- Distal Bile Duct Adenocarcinoma
- +7 more
- Cisplatin
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen
Recruiting
- Acinar Cell Carcinoma
- +93 more
- Biospecimen Collection
- +2 more
-
Birmingham, Alabama
- +998 more
Aug 23, 2022
Bile Duct Carcinoma, Gallbladder Carcinoma, Pancreatic Ductal Adenocarcinoma Trial in Houston (Endoscopic Retrograde
Recruiting
- Bile Duct Carcinoma
- +2 more
- Endoscopic Retrograde Cholangiopancreatography
-
Houston, TexasM D Anderson Cancer Center
Jul 10, 2022
Comprehensive Genomic Profiling Combined With Real Life Data of
Active, not recruiting
- Gallbladder Carcinoma
-
Frankfurt am Main, GermanyInstitut für Klinische Krebsforschung IKF GmbH
Jan 31, 2022
Advanced Biliary Tract Cancer, Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma Trial in Hangzhou (Irinotecan
Not yet recruiting
- Advanced Biliary Tract Cancer
- +3 more
- Irinotecan Liposome Injection
- +3 more
-
Hangzhou, Zhejiang, ChinaCancer Hospital of the University of Chinese Academy of Sciences
Sep 16, 2021
Biliary Tract Carcinoma, Gallbladder Carcinoma Trial in Toronto (Selumetinib, Cisplatin, Gemcitabine)
Active, not recruiting
- Biliary Tract Carcinoma
- Gallbladder Carcinoma
- Selumetinib
- +2 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 14, 2021
Cholangiocarcinoma, Gallbladder Carcinoma, Hepatocellular Carcinoma Trial in Xuzhou (biliary stent)
Completed
- Cholangiocarcinoma
- +2 more
- biliary stent
-
Xuzhou, Jiangsu, ChinaXuzhou Central Hospital
Nov 18, 2018
Circulating Exosome Proteomics In Gallbladder Carcinoma Patients
Unknown status
- Proteinosis
- Gallbladder Carcinoma
-
Shanghai, Shanghai, ChinaXinhua Hospital
Jul 8, 2018
Biliary Tract Carcinoma, Gallbladder Carcinoma Trial (MEK 162, Gemcitabine, Oxaliplatin)
Withdrawn
- Biliary Tract Carcinoma
- Gallbladder Carcinoma
- MEK 162
- +2 more
- (no location specified)
Feb 14, 2018
Adenocarcinoma of Unknown Primary, Adult Cholangiocarcinoma, Gallbladder Carcinoma Trial in United States (Paclitaxel
Completed
- Adenocarcinoma of Unknown Primary
- +16 more
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation
- +4 more
-
Chicago, Illinois
- +7 more
Dec 8, 2017
Permission to Collect Blood Over Time for Research
Terminated
- Pancreatic Cancer
- +13 more
- Observation
-
Stanford, CaliforniaStanford University School of Medicine
Jul 6, 2016